166
Views
2
CrossRef citations to date
0
Altmetric
Original Research

The Influence of Blue-Filtering Intraocular Lenses Implant on Exudative Age-Related Macular Degeneration: A Case–Control Study

, , , & ORCID Icon
Pages 2287-2292 | Published online: 01 Jun 2021

References

  • Coleman HR, Chan -C-C, Ferris FL, Chew EY. Age-related macular degeneration. Lancet. 2008;372:1835–1845. doi:10.1016/S0140-6736(08)61759-6
  • Klein RJ, Zeiss C, Chew EY, et al. Complement Factor H polymorphism in age-related macular degeneration. Science. 2005;308:385–389. doi:10.1126/science.1109557
  • Bressler NM, Silva JC, Bressler SB, Fine SL, Green WR. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. 1994. Retina. 2005;25(5 Suppl):130–142. doi:10.1097/00006982-200507001-00016
  • Beatty S, Boulton M, Henson D, Koh -H-H, Murray IJ. Macular pigment and age-related macular degeneration. Br J Ophthalmol. 1999;83(7):867–877. doi:10.1136/bjo.83.7.867
  • Noell WK, Walker VS, Kang BS, Berman S. Retinal damage by light in rats. Invest Ophthalmol. 1966;5(5):450–473.
  • Davies S, Elliott MH, Floor E, et al. Photocytotoxicity of lipofuscin in human retinal pigment epithelial cells. Free Radic Biol Med. 2001;31(2):256–265. doi:10.1016/S0891-5849(01)00582-2
  • Sparrow JR, Miller AS, Zhou J. Blue light-absorbing intraocular lens and retinal pigment epithelium protection in vitro. J Cataract Refract Surg. 2004;30(4):873–878. doi:10.1016/j.jcrs.2004.01.031
  • Sui GY, Liu GC, Liu GY, et al. Is sunlight exposure a risk factor for age-related macular degeneration? A systematic review and meta-analysis. Br J Ophthalmol. 2013;97(4):389–394. doi:10.1136/bjophthalmol-2012-302281
  • Van Norren D, Van De Kraats J. Spectral transmission of intraocular lenses expressed as a virtual age. Br J Ophthalmol. 2007;91(10):1374–1375. doi:10.1136/bjo.2007.117903
  • Mainster MA. The spectra, classification, and rationale of ultraviolet-protective intraocular lenses. Am J Ophthalmol. 1986;102(6):727–732. doi:10.1016/0002-9394(86)90400-9
  • Downie LE, Busija L, Keller PR. Blue-light filtering intraocular lenses (IOLs) for protecting macular health. Cochrane Database Syst Rev. 2018;5(5):CD011977. doi:10.1002/14651858.CD011977.pub2
  • Brockmann C, Schulz M, Laube T. Transmittance characteristics of ultraviolet and blue-light-filtering intraocular lenses. J Cataract Refract Surg. 2008;34(7):1161–1166. doi:10.1016/j.jcrs.2008.03.039
  • Mainster MA. Violet and blue light blocking intraocular lenses: photoprotection versus photoreception. Br J Ophthalmol. 2006;90(6):784–792. doi:10.1136/bjo.2005.086553
  • Symes RJ, Cuthbertson FM. Blue-blocking intraocular implants should be used routinely during phacoemulsification surgery-Yes. Eye. 2012;26:1397–1399. doi:10.1038/eye.2012.178
  • Lee RMH, Lam FC, Liu CSC. Blue-blocking intraocular implants should be used routinely during phacoemulsification surgery-No. Eye. 2012;26(11):1400–1401. doi:10.1038/eye.2012.177
  • Mainster MA, Turner PL. Blue-blocking IOLs vs. short-wavelength visible light: hypothesis-based vs. evidence-based medical practice. Ophthalmology. 2011;118(1):1–2. doi:10.1016/j.ophtha.2010.11.016
  • Pipis A, Touliou E, Pillunat LE, Augustin AJ. Effect of the blue filter intraocular lens on the progression of geographic atrophy. Eur J Ophthalmol. 2015;25(2):128–133. doi:10.5301/ejo.5000520
  • Nagai H, Hirano Y, Yasukawa T, et al. Prevention of increased abnormal fundus autofluorescence with blue light–filtering intraocular lenses. J Cataract Refract Surg. 2015;41(9):1855–1859. doi:10.1016/j.jcrs.2015.01.017
  • Sperduto RD, Hiller R. Systemic hypertension and age-related maculopathy in the framingham study. Arch Ophthalmol. 1986;104(2):216–219. doi:10.1001/archopht.1986.01050140070022
  • Friedman DS, O’Colmain BJ, Muñoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122(4):564–572. doi:10.1001/archopht.122.4.564
  • Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. Smoking and age-related macular degeneration: a review of association. Eye. 2005;19(9):935–944. doi:10.1038/sj.eye.6701978
  • Klein R, Klein BEK, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 2003;110(4):636–643. doi:10.1016/S0161-6420(03)00599-2
  • Wilson HL, Schwartz DM, Bhatt HRF, McCulloch CE, Duncan JL. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am J Ophthalmol. 2004;137(4):615–624. doi:10.1016/j.ajo.2003.10.025
  • Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417–1436. doi:10.1001/archopht.119.10.1417
  • Marie M, Gondouin P, Pagan D, et al. Blue-violet light decreases VEGFa production in an in vitro model of AMD. PLoS One. 2019;14(10):e0223839. doi:10.1371/journal.pone.0223839
  • Achiron A, Elbaz U, Hecht I, et al. The effect of blue-light filtering intraocular lenses on the development and progression of neovascular age-related macular degeneration. Ophthalmology. 2021;128(3):410–416. doi:10.1016/j.ophtha.2020.07.039
  • Hammond BR, Sreenivasan V, Suryakumar R. The effects of blue light–filtering intraocular lenses on the protection and function of the visual system. Clin Ophthalmol. 2019;13:2427–2438. doi:10.2147/OPTH.S213280